Formulation and study of nebivolol containing orodispersable tablets

1. Badgujar B, Mundada A. The technologies used for developing orally disintegrating tablets: A review. Acta Pharm. 2011, 61:117-13910.2478/v10007-011-0020-8Search in Google Scholar

2. Bandari S, Mittapalli R, Gannu R, Rao Y. Orodispersible tablets: An overview. Asian Journal of Pharmaceutics. 2008, 2(1):2-11.10.4103/0973-8398.41557Search in Google Scholar

3. Battu SK, Repka MA, Majumdar S, Rao Y M. Formulation and Evaluation of Rapidly Disintegrating Fenoverine Tablets: Effect of Superdisintegrants. Drug Development and Industrial Pharmacy. 2007; 33(11):1225-32.10.1080/03639040701377888Search in Google Scholar

4. Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, et al. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. The World Journal of Biological Psychiatry. 2010, 11(7):894-903.10.3109/15622975.2010.505663Search in Google Scholar

5. Dey P, Maiti S. Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med. 2010, 1(1):2-5.10.4103/0976-9668.71663Search in Google Scholar

6. Navarro V. Improving medication compliance in patients with depression: Use of orodispersible tablets. Advances in Therapy. 2010, 27(11):785-95.10.1007/s12325-010-0073-ySearch in Google Scholar

7. Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011;2(4):223-35.10.4103/2231-4040.90877Search in Google Scholar

8. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical Science & Technology Today. 2000, 3(2):58-63.10.1016/S1461-5347(99)00237-0Search in Google Scholar

9. Mohanachandran P, Sindhumol P, Kiran T. Superdisintegrants: an overview. Int J Pharm Sci Rev Res. 2011, 6(1):105-9.Search in Google Scholar

10. Shihora H, Panda S. Superdisintegrants, utility in dosage forms: a quick review. J Pharm Sci Biosci Res. 2011, 1(3):148-53.Search in Google Scholar

11. Zhao N, Augsburger LL. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS PharmSciTech. 2005, 6(4):E634-E40.10.1208/pt060479275061216408865Search in Google Scholar

12. Vijayanand P, Patil JS, Reddy MV. Formulation and comparative pharmacokinetic evaluation of orodispersible tablets and films of nebivolol hydrochloride. J Pharm Investig. 2015, 45(2):237-47.10.1007/s40005-014-0169-5Search in Google Scholar

13. Sravani M. Formulation and Evaluation of Mouth Dissolving Tablets of Nebivolol HCl for Treatment of Hypertension. Int. j. pharma chem. res. 2017, 3(4):756-74.Search in Google Scholar

14. ****European Pharmacopeeia 10th Edition. 2019:432-567.Search in Google Scholar